Table 1.
Case | Sex | Age | HB(g/l) | WB(*109/l) | PLT(*109/l) | Cytogenetic | BLASTa | IPSS |
---|---|---|---|---|---|---|---|---|
1b | M | 60 | 74 | 3.6 | 15 | Complex | 3% | 1.5 |
2b | M | 52 | 87 | 3.4 | 14 | -7 | 2.5% | 1 |
3 | M | 63 | 83 | 3.1 | 42 | Normal | 1% | 0.5 |
4b | M | 70 | 42 | 2.1 | 43 | Normal | 0.5% | 0.5 |
5 | F | 69 | 70 | 3.8 | 26 | Normal | 1% | 0.5 |
6 | M | 64 | 76 | 1.6 | 79 | t(4,21) | 0 | 1 |
7b | M | 33 | 53 | 3.9 | 18 | Normal | 3.5% | 0.5 |
8 | F | 84 | 57 | 4.6 | 90 | Normal | 4.5% | 0.5 |
9 | M | 52 | 52 | 1.9 | 62 | Normal | 3% | 0.5 |
10 | M | 65 | 94 | 11 | 77 | Complex | 3% | 1.5 |
11b | M | 77 | 111 | 8.7 | 15 | Normal | 2% | 0 |
12 | F | 71 | 57 | 2.2 | 45 | Normal | 1% | 0.5 |
13 | F | 52 | 50 | 1.5 | 19 | Normal | 0.5% | 0.5 |
14 | M | 72 | 83 | 3.7 | 122 | Normal | 0% | 0 |
15 | F | 60 | 78 | 2.7 | 78 | Normal | 0.5% | 0.5 |
16b | M | 69 | 58 | 5.4 | 458 | 5q-,20q- | 0% | 0 |
17 | M | 56 | 63 | 2.4 | 56 | Normal | 0.5% | 0.5 |
18 | M | 47 | 71 | 3.1 | 68 | 20q-,+8 | 0.5% | 1 |
19 | M | 76 | 68 | 2.4 | 209 | Normal | 1% | 0 |
20 | F | 58 | 54 | 2.2 | 74 | 5q- | 1% | 0.5 |
21 | M | 50 | 86 | 2.8 | 26 | Normal | 3% | 0.5 |
22 | M | 52 | 54 | 1.6 | 78 | Complex | 1% | 1.5 |
23 | M | 62 | 75 | 5.2 | 18 | Normal | 0.5% | 0.5 |
24b | M | 53 | 78 | 2.9 | 116 | Normal | 0.5% | 0 |
25 | M | 60 | 49 | 11 | 31 | Normal | 0.5% | 0.5 |
26 | M | 17 | 77 | 4.7 | 10 | Normal | 0 | 0.5 |
27 | M | 66 | 43 | 4.4 | 24 | 20q- | 2% | 0.5 |
28 | M | 43 | 121 | 5.9 | 72 | Normal | 0 | 0 |
29b | M | 29 | 64 | 6.4 | 36 | Complex | 1.5% | 1.5 |
30 | M | 39 | 95 | 2.6 | 54 | Complex | 1.5% | 1.5 |
31b | M | 52 | 89 | 21 | 67 | Normal | 8.5% | 1 |
32 | F | 37 | 58 | 3.2 | 44 | Normal | 6.5% | 1 |
33b | F | 54 | 50 | 2.4 | 4 | Normal | 10% | 2 |
34b | F | 46 | 78 | 5.7 | 810 | Normal | 8.5% | 0.5 |
35b | F | 74 | 62 | 2 | 119 | Normal | 10% | 1.5 |
36b | M | 39 | 93 | 2.8 | 31 | Normal | 10% | 2 |
37 | M | 41 | 111 | 3.6 | 16 | Normal | 11.5% | 1.5 |
38b | M | 67 | 139 | 3.4 | 32 | Normal | 11% | 1.5 |
39b | M | 64 | 67 | 4.7 | 348 | Normal | 15.5% | 1.5 |
40 | M | 51 | 64 | 1.4 | 20 | Normal | 20% | 2.5 |
41 | M | 44 | 40 | 1.7 | 24 | Complex | 9.5% | 2 |
42 | M | 53 | 56 | 1.6 | 44 | Complex | 10.5% | 3 |
43 | F | 64 | 64 | 2 | 88 | 5q- | 16.5% | 2 |
44 | M | 37 | 66 | 6 | 10 | Normal | 10% | 2 |
45 | F | 21 | 48 | 4 | 27 | Normal | 6.5% | 1 |
46 | M | 50 | 56 | 2.2 | 19 | 20q- | 7% | 1 |
47 | F | 77 | 91 | 7.2 | 117 | Complex | 10% | 2.5 |
48b | M | 70 | 104 | 2.6 | 18 | t(1,1),20q- | 20% | 2.5 |
49b | F | 55 | 59 | 1.7 | 33 | +11 | 7% | 1 |
MDS: myelodysplastic syndromes
HB: haemoglobin
WB: white blood cells
PLT: platelets
M means male
F means female
IPSS: international prognostic scoring system score
“a” blast was calculated in 200 bone marrow karyocytes
“b” CD34+ cells of bone marrow were collected (data in Fig.1C)
“Complex” means more than two abnormities.